Add Company
Join Now

Senseera Revenue and Competitors

License our Company Data API

Jerusalem, il

Location

N/A

Total Funding

Biotech

Industry

Employee Data

  • Senseera has 19 Employees.(i)
  • Senseera grew their employee count by 6% last year.

Senseera's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A2353%N/AN/A
#2
N/A4940%N/AN/A
#3
N/A327%N/AN/A
#4
N/A15-6%N/AN/A
#5
N/A4326%N/AN/A
#6
N/A280%N/AN/A
#7
N/A90%N/AN/A
#8
N/A249%N/AN/A
#9
N/A80%N/AN/A
#10
N/A196%N/AN/A
Add Company

What Is Senseera?

Senseera's GEM (Genomic Expression Maps) BIOMARKERS, is a novel biomarker discovery platform based on a patent protected chromatin epigenomics (cfChIP-seq) liquid biopsy technology (Sadeh, Nature Biotechnology, 2021). \n\nGEM BIOMARKERS turns a simple blood draw into unparalleled, quantitative, cell-specific gene expression, and regulation data from cell-free DNA. Going beyond traditional methods like cfDNA genomics and methylation, it offers a transformative layer of data for various applications including biomarker discovery, tissue-agnostic MRD detection, response to therapy, dose optimization, disease subtyping and more.\n\nBacked by a database of over 20,000 annotated disease samples and a 2,000+ healthy subjects cohort, Senseera is collaborating with leading drug developers from big pharma and biotechs, to deliver mechanistic insights with exceptional sensitivity and specificity across multiple indications, advancing human health and precision medicine worldwide.

keywords:N/A

N/A

Total Funding

19

Number of Employees

N/A

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.1M200%N/A
#2
$5.3M215%N/A
#3
$4.9M22-4%N/A
#4
$3M26-4%N/A
#5
$3.7M26-4%N/A